Targeting the tyrosine phosphatase SHP2 is efficacious against HER2-positive breast cancer

被引：0
|
作者：
Agazie, Yehenew [1 ]
Hartman, Zachary [1 ]
机构：
[1] West Virginia Univ, Morgantown, WV 26506 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P3-10-20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-10-20
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Targeting HER2-positive breast cancer: advances and future directions
    Swain, Sandra M.
    Shastry, Mythili
    Hamilton, Erika
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (02) : 101 - 126
  • [22] Targeting HER2-positive breast cancer: advances and future directions
    Sandra M. Swain
    Mythili Shastry
    Erika Hamilton
    Nature Reviews Drug Discovery, 2023, 22 : 101 - 126
  • [23] A systematic review of dual targeting in HER2-positive breast cancer
    Kumler, Iben
    Tuxen, Malgorzata K.
    Nielsen, Dorte Lisbet
    CANCER TREATMENT REVIEWS, 2014, 40 (02) : 259 - 270
  • [24] Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
    Zeng, Li-Fan
    Zhang, Ruo-Yu
    Yu, Zhi-Hong
    Li, Sijiu
    Wu, Li
    Gunawan, Andrea M.
    Lane, Brandon S.
    Mali, Raghuveer S.
    Li, Xingjun
    Chan, Rebecca J.
    Kapur, Reuben
    Wells, Clark D.
    Zhang, Zhong-Yin
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (15) : 6594 - 6609
  • [25] Protein Tyrosine Phosphatase SHP2 Controls Interleukin-8 Expression in Breast Cancer Cells
    Romain J. Amante
    Priska Auf der Maur
    Veronica Richina
    Atul Sethi
    Vytautas Iesmantavicius
    Debora Bonenfant
    Nicola Aceto
    Mohamed Bentires-Alj
    Journal of Mammary Gland Biology and Neoplasia, 2022, 27 : 145 - 153
  • [26] Protein Tyrosine Phosphatase SHP2 Controls Interleukin-8 Expression in Breast Cancer Cells
    Amante, Romain J.
    Maur, Priska Auf Der
    Richina, Veronica
    Sethi, Atul
    Iesmantavicius, Vytautas
    Bonenfant, Debora
    Aceto, Nicola
    Bentires-Alj, Mohamed
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2022, 27 (02) : 145 - 153
  • [27] HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now
    Schlam, Ilana
    Swain, Sandra M.
    NPJ BREAST CANCER, 2021, 7 (01)
  • [28] Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer
    Singh, Desh Deepak
    Lee, Hae-Jeung
    Yadav, Dharmendra Kumar
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [29] Tyrosine kinase inhibitors for brain metastases in HER2-positive breast cancer
    Duchnowska, Renata
    Loibl, Sibylle
    Jassem, Jacek
    CANCER TREATMENT REVIEWS, 2018, 67 : 71 - 77
  • [30] HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now
    Ilana Schlam
    Sandra M. Swain
    npj Breast Cancer, 7
12345